Osama Saher

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Single Molecule

Top Venues

Nucleic acid therapeutics

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Osama Saher, Eman M Zaghloul, Tea Umek, Daniel W Hagey, Negin Mozafari, Mathias B Danielsen, Alaa S Gouda, Karin E Lundin, Per T Jørgensen, Jesper Wengel, C I Edvard Smith, Rula Zain
Chemical Modifications and Design Influence the Potency of Huntingtin Antigene Oligonucleotides. Nucleic acid therapeutics (2023)
Daniel W Hagey, Miina Ojansivu, R Beklem Bostancioglu, Osama Saher, Jeremy P Bost, Manuela O Gustafsson, Roberto Gramignoli, Mathias G Svahn, Dhanu Gupta, Molly M Stevens, Andre Görgens, Samir El Andaloussi
The cellular response to extracellular vesicles is dependent on their cell source and dose. Science advances 9 (35) (2023)
Osama Saher, Eman M Zaghloul, Tea Umek, Daniel W Hagey, Negin Mozafari, Mathias B Danielsen, Alaa S Gouda, Karin E Lundin, Per T Jørgensen, Jesper Wengel, C I Edvard Smith, Rula Zain
Chemical Modifications and Design Influence the Potency of Huntingtin Anti-Gene Oligonucleotides. Nucleic acid therapeutics (2023)
Jeremy P Bost, Miina Ojansivu, Michael J Munson, Emelie Wesén, Audrey Gallud, Dhanu Gupta, Oskar Gustafsson, Osama Saher, Julia Rädler, Stuart G Higgins, Taavi Lehto, Margaret N Holme, Anders Dahlén, Ola Engkvist, Per-Erik Strömstedt, Shalini Andersson, Carl Inge Edvard Smith, Molly M Stevens, Elin K Esbjörner, Anna Collén, Samir El Andaloussi
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides. Communications biology 5 (1) (2022)
Tõnis Lehto, Tõnis Lehto, Rahel Tops, Olof Gissberg, Dhanu Gupta, Burcu Bestas, Jeremy P Bost, Oscar P B Wiklander, Helena Sork, Eman M Zaghloul, Doste R Mamand, Mattias Hällbrink, Rannar Sillard, Osama Saher, Kariem Ezzat, Carl Inge Edvard Smith, Samir El Andaloussi, Taavi Lehto
Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo. Biomedicines 9 (8) (2021)
Haneen Daralnakhla, Osama Saher, Susanna Zamolo, Tõnis Lehto, Jeremy P Bost, Marc Heitz, Karin E Lundin, Samir El Andaloussi, Tamis Darbre, Jean-Louis Reymond, Rula Zain, Carl Inge Edvard Smith
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides. Pharmaceutics 13 (1) (2021)
Jeremy P Bost, Osama Saher, Daniel Hagey, Doste R Mamand, Xiuming Liang, Wenyi Zheng, Giulia Corso, Oskar Gustafsson, André Görgens, Ci Edvard Smith, Rula Zain, Samir El Andaloussi, Dhanu Gupta
Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles. Advanced healthcare materials (2021)
Dhanu Gupta, Xiuming Liang, Svetlana Pavlova, Oscar P B Wiklander, Giulia Corso, Ying Zhao, Osama Saher, Jeremy Bost, Antje M Zickler, Andras Piffko, Cecile L Maire, Franz L Ricklefs, Oskar Gustafsson, Virginia Castilla Llorente, Manuela O Gustafsson, R Beklem Bostancioglu, Doste R Mamand, Daniel W Hagey, Andre Görgens, Joel Z Nordin, Samir El Andaloussi
Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. Journal of extracellular vesicles 9 (1) (2020)
Madhuri Hande, Osama Saher, Karin E Lundin, Carl Inge Edvard Smith, Rula Zain, Tuomas Antti Lönnberg
Oligonucleotide⁻Palladacycle Conjugates as Splice-Correcting Agents. Molecules (Basel, Switzerland) 24 (6) (2019)
Osama Saher, Taavi Lehto, Olof Gissberg, Dhanu Gupta, Oskar Gustafsson, Samir El Andaloussi, Tamis Darbre, Karin E Lundin, Carl Inge Edvard Smith, Rula Zain
Sugar and Polymer Excipients Enhance Uptake and Splice-Switching Activity of Peptide-Dendrimer/Lipid/Oligonucleotide Formulations. Pharmaceutics 11 (12) (2019)